We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
Cap. Flow
+$2.97B
Cap. Flow %
6.1%
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$305M
2
CVS icon
CVS Health
CVS
+$190M
3
NVS icon
Novartis
NVS
+$175M
4
AVGO icon
Broadcom
AVGO
+$154M
5
WDC icon
Western Digital
WDC
+$144M

Sector Composition

Rank Sector Weight
1 Financials 24.38%
2 Healthcare 15.25%
3 Technology 13.09%
4 Industrials 10.62%
5 Energy 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTAP icon
51
NetApp
NTAP
$32.9B
$287M 0.59%
6,971,291
+1,048,642
+18% +$42.6M
EMC
52
DELISTED
EMC CORPORATION
EMC
$285M 0.59%
11,346,061
+5,784,555
+104% +$140M
STX icon
53
Seagate
STX
$193B
$275M 0.56%
4,904,131
-522,408
-10% -$25.8M
UNH icon
54
UnitedHealth
UNH
$382B
$270M 0.55%
3,586,599
-3,021,827
-46% -$217M
FLEX icon
55
Flex
FLEX
$43.4B
$262M 0.54%
44,776,377
+8,375,623
+23% +$50.9M
VR
56
DELISTED
Validus Hold Ltd
VR
$258M 0.53%
6,407,855
+356,585
+6% +$13.9M
NSC icon
57
Norfolk Southern
NSC
$78.8B
$243M 0.5%
2,618,616
+268,467
+11% +$23M
PARA
58
DELISTED
Paramount Global Class B
PARA
$242M 0.5%
3,794,324
-2,324,409
-38% -$137M
AXS icon
59
AXIS Capital
AXS
$8.59B
$241M 0.49%
5,061,462
-435,344
-8% -$20.6M
TRV icon
60
Travelers Companies
TRV
$80.8B
$236M 0.48%
2,603,290
+48,057
+2% +$4.2M
EQR icon
61
Equity Residential
EQR
$25.4B
$235M 0.48%
4,531,275
+670,435
+17% +$35.3M
ARW icon
62
Arrow Electronics
ARW
$10.9B
$233M 0.48%
4,285,807
+415,534
+11% +$21.1M
MAN icon
63
ManpowerGroup
MAN
$2.39B
$227M 0.46%
2,639,004
-188,254
-7% -$15.1M
SLB icon
64
SLB Ltd
SLB
$77.8B
$225M 0.46%
2,494,790
+185,483
+8% +$16.7M
GL icon
65
Globe Life
GL
$13.5B
$222M 0.45%
4,256,492
-108,234
-2% -$5.4M
QCOM icon
66
Qualcomm
QCOM
$176B
$220M 0.45%
2,958,674
+802,639
+37% +$56.6M
GS icon
67
Goldman Sachs
GS
$313B
$218M 0.45%
1,231,537
+128,535
+12% +$21.2M
ABBV icon
68
AbbVie
ABBV
$458B
$218M 0.45%
4,120,933
+207,777
+5% +$10.2M
IP icon
69
International Paper
IP
$22.3B
$212M 0.43%
4,621,480
+698,747
+18% +$29.9M
EGN
70
DELISTED
Energen
EGN
$207M 0.42%
2,921,259
+268,425
+10% +$20.2M
L icon
71
Loews
L
$24.3B
$204M 0.42%
4,235,917
+85,420
+2% +$4.08M
RJF icon
72
Raymond James Financial
RJF
$32.5B
$203M 0.42%
5,824,910
+741,641
+15% +$23M
AVT icon
73
Avnet
AVT
$7.33B
$202M 0.41%
4,588,697
+120,867
+3% +$4.99M
ATVI
74
DELISTED
Activision Blizzard
ATVI
$202M 0.41%
11,310,211
+848,361
+8% +$14.6M
GPK icon
75
Graphic Packaging
GPK
$3.26B
$201M 0.41%
20,974,385
+6,114,652
+41% +$53.6M

Similar funds

Boston Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.

  • Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
  • Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
  • Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
  • Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
  • Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
  • Boston Partners opened 71 new positions and closed 53 in Q4 2013.
  • Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.

Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.